Guillain-Barre Syndrome Associated With COVID-19 Infection: A Case Report With Review of Literature
- PMID: 33728118
- PMCID: PMC7935237
- DOI: 10.7759/cureus.13096
Guillain-Barre Syndrome Associated With COVID-19 Infection: A Case Report With Review of Literature
Abstract
COVID-19 has become a pandemic. It affects multiple systems of the body including the nervous system. It invades the nervous systems through multiple routes - either olfactory tract, bloodstream (by binding to endothelial receptors) or via ACE-2 receptors in the brain. We report a case of Guillain-Barré syndrome (GBS) variant (acute motor axonal neuropathy (AMAN type)) associated with COVID-19 infection with positive polymerase chain reaction (PCR) test for COVID-19 and positive contact history with infected family member. GBS and its variants like AMAN can occur due to COVID-19 infection through its immune-mediated effects. Diagnosis of GBS should depend on the clinical and supportive criteria. The treatment should be started early to prevent progression and disease co-morbidities.
Keywords: acute motor axonal neuropathy; covid-19; guillain-barré syndrome.
Copyright © 2021, Meshref et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. Baig AM, Khaleeq A, Ali U, Syeda H. ACS Chem Neurosci. 2020;11:995–998. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous